Welcome to MEDRO Middle East & North Africa DOXAL Regional Office

Inactivated Saccharomyces cerevisiae

European Patent;  EP0111202A1

Composition: each Kg contains

Thepax contains less than  10 x 109 CFU/ per gram of stabilized cells of Saccharomyces cerevisiae var. Ellipsoideus.

Indication:

Thepax is a suitable prebiotic to be used in livestock to help meeting specific nutritional requirements that occur in animals during their physiological productive conditions.

In ruminants Thepax contributes to increase the number of digestive micro flora in order to help the animal to utilize the feed, through

  • Release of nutrients content to micro flora
  • Increase number of digestive bacteria population¬∑ Keep rumen pH fluctuations
  • Improve FCR
  • Increase animal performances
  • Decrease production unit cost

In monogastrics Thepax helps large intestine micro flora to limit the growth of pathogenic bacteria, by direct and indirect effects, leading to:

  • Reduced incidence of abnormal fermentation with reduction in toxin production
  • Rapid recovery of digestive micro flora following antibiotic treatments
  • Improve resistance to stress
  • Improvement in performances, by increasing feed intake and FCR.
  • Improvement in the animals overall health and condition;

Dosage and Administration:

  • Calves: 500 g/ton of final feed
  • Beef cattle: 600 g/ ton of final feed
  • Dairy cows: 500 g/ ton of final feed
  • Broilers and turkeys as starter: 500 g/ton of final feed
  • Broilers and turkeys as finisher: 250 g/ton of final feed
  • Layers: 250-350 g/ton of final feed

Package:

25 kg bag

Withdrawal Time

0 day